Literature DB >> 9770878

Parity as a risk factor for cancer cervix.

V Gawande1, S N Wahab, S P Zodpey, N D Vasudeo.   

Abstract

The present hospital based, group matched case control study was carried out at Gynecology Clinic, Govt. Medical College hospital, Nagpur, to investigate role of parity in the outcome of cancer cervix. The study included 230 cases of cancer cervix and equal number of controls, matched for age. The study identified significance of multiparity, as a risk factor for cancer cervix. Estimates of attributable risk proportion (ARP) and population attributable risk proportion (PARP) endorsed etiological and preventable role of multiparity in the outcome of cervical cancer, respectively.

Entities:  

Mesh:

Year:  1998        PMID: 9770878

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  2 in total

1.  External Beam Therapy in a Four-Field Box Technique with Paclitaxel versus a Two-Field Technique with Cisplatin in Locally Advanced Carcinoma Cervix: A Phase II Monocentric Trial.

Authors:  Vijayakumar Narayanan; Bibek Bista; Samir Sharma
Journal:  ISRN Oncol       Date:  2012-12-31

2.  Awareness of cervical cancer among women in Malaysia.

Authors:  Lee Mun Seng; Aina Najwa Rosman; Almas Khan; Najwa Md Haris; Nur Alyan Syahmi Mustapha; Nur Sakina Muhammad Husaini; Nurul Fadhilah Zahari
Journal:  Int J Health Sci (Qassim)       Date:  2018 Jul-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.